PMID- 32285751 OWN - NLM STAT- MEDLINE DCOM- 20210308 LR - 20210308 IS - 2047-9980 (Electronic) IS - 2047-9980 (Linking) VI - 9 IP - 8 DP - 2020 Apr 21 TI - Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices. PG - e015449 LID - 10.1161/JAHA.119.015449 [doi] LID - e015449 AB - Background This study evaluated the impact of adverse events (AEs) on the development of subsequent AEs after left ventricular assist device (LVAD) surgery. Methods and Results The INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) was used to identify primary durable LVADs implanted between 2006 and 2016. The temporal relationships between AEs occurring during the index hospitalization were evaluated using separate risk-adjusted Cox proportional hazard models. LVADs were implanted in 18 763 patients. The strongest positive relationships were renal failure leading to hepatic dysfunction (hazard ratio [HR], 6.62; 95% CI, 5.12-8.54; P<0.001), respiratory failure leading to renal failure (HR, 5.51; 95% CI, 4.79-6.34; P<0.001), respiratory failure leading to hepatic dysfunction (HR, 4.36; 95% CI, 3.25-5.83; P<0.001), renal failure leading to respiratory failure (HR, 4.18; 95% CI, 3.76-4.64; P<0.001), and renal failure leading to right ventricular assist device implant (HR, 3.70; 95% CI, 2.31-5.90; P<0.001). Although bleeding, infection, and right ventricular assist device implant were each associated with several subsequent AEs, the magnitude of association was less substantial. The lowest 1-year post-LVAD survival was associated with the primary AEs of renal failure (68.1%) and respiratory failure (70.7%) (log-rank P<0.001). Conclusions Most in-hospital AEs after LVAD implantation have a significant association with the development of subsequent AEs, with the most profound impact associated with primary renal or respiratory failure, which are also associated with the lowest 1-year survival. Targeting the reduction of renal or respiratory failure as the primary AE after LVAD surgery would likely yield the greatest reductions in overall AE burden and subsequent mortality. FAU - Kilic, Arman AU - Kilic A AD - Division of Cardiac Surgery University of Pittsburgh Medical Center Pittsburgh PA. FAU - Seese, Laura AU - Seese L AD - Division of Cardiac Surgery University of Pittsburgh Medical Center Pittsburgh PA. FAU - Pagani, Francis AU - Pagani F AD - Department of Cardiac Surgery University of Michigan Ann Arbor MI. FAU - Kormos, Robert AU - Kormos R AD - Division of Cardiac Surgery University of Pittsburgh Medical Center Pittsburgh PA. LA - eng PT - Journal Article DEP - 20200414 PL - England TA - J Am Heart Assoc JT - Journal of the American Heart Association JID - 101580524 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Databases, Factual MH - Female MH - Heart Failure/mortality/physiopathology/*therapy MH - *Heart-Assist Devices MH - Humans MH - Incidence MH - Male MH - Middle Aged MH - North America MH - Prosthesis Implantation/*adverse effects/*instrumentation/mortality MH - Registries MH - Renal Insufficiency/*epidemiology/mortality MH - Respiratory Insufficiency/*epidemiology/mortality MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Time Factors MH - Treatment Outcome MH - Ventricular Function, Left MH - Young Adult PMC - PMC7428534 OTO - NOTNLM OT - complications OT - heart failure OT - left ventricular assist device EDAT- 2020/04/15 06:00 MHDA- 2021/03/09 06:00 PMCR- 2020/04/21 CRDT- 2020/04/15 06:00 PHST- 2020/04/15 06:00 [pubmed] PHST- 2021/03/09 06:00 [medline] PHST- 2020/04/15 06:00 [entrez] PHST- 2020/04/21 00:00 [pmc-release] AID - JAH35000 [pii] AID - 10.1161/JAHA.119.015449 [doi] PST - ppublish SO - J Am Heart Assoc. 2020 Apr 21;9(8):e015449. doi: 10.1161/JAHA.119.015449. Epub 2020 Apr 14.